Season 2 of the MedCity Pivot Podcast has launched with a special focus on the evolution of phamacy and pharmacy benefit management. The first guest this season is A.J. Loiacono, who leads Capital Rx, a newer generation of PBM that is tech enabled and driven by a goal to be transparent and not have hidden costs and fees.
Loiacono has been fiery and eloquent in the past, even calling the actions of the heavyweights of the PBM worlds — CVS Health Caremark, Unitedhealth Optum and Cigna Express Scripts — neither sustainable nor ethical. In this episode, though, there was less fire and brimstone though he did acknowledge that they have conflicts of interest.
Capital Rx has found investors in both traditional PBMs like Prime Therapeutics and even large health systems, so it seemed only fitting to sit down with Loiacono to talk how the world of pharmacies and PBMs are evolving.
